Pulled from www.sightings.com site
SIGHTINGS
URGENT
Chemtrail Culprits Identified?
BioWarfare Countermeasures Being Tested?
From Bill Hamilton
1-22-2000
Note: We originally alerted you to some of this incredible
information about Chemtrails/Aerial Vaccines last month.
The following was sent by a friend was this quote from 'THE SPOTLIGHT." Whether true or not, this might lead to someone doing some FOIA requests to find out.
National Security Agency (NSA)...Anti-bacteriological, VIRUSES and SPORES warfare?
THE SPOTLIGHT
Warfare Chemicals being Tested: The strange-looking streaks in the sky aren't your imagination.
They are anti-bacteriological warfare chemicals being tested by the federal government. And the public has been kept in the dark.
The chemical spraying to the "unconventional pathogen countermeasures program" of the top secret Defense Advanced Research Projects Agency (DARPA).
NOTE : Novavax is a bio pharmaceuticals company. BCTP is made of water, soybean oil, Triton X 100 detergent and the solvent tri-n-butyl phosphate. BCTP envelops the VIRUSES and SPORES, causing them to explode and thus destroying them upon contact.
http://www.spotlight.org/01_07_00/Chemicals/chemicals.html
********* Novavax, Inc. : http://www.novavax.com/
NOTE : BCTP's research studies were funded by the Defense Advanced Research Projects Agency (DARPA).
BCTP appears to inactivate the virus on contact."
The research is funded by DARPA's "Unconventional Pathogen Countermeasures Program"
[GO TO : http://www.darpa.mil/DSO/rd/UPC/index.html ].
The U-M and Novavax have filed a patent application covering BCTP's use as a decontamination agent for various anti-microbial applications.
*** There IS an "Alien" INVADER Biological THREAT! Research and Development Areas : http://www.darpa.mil/DSO/rd/Abmt/Pathogen.html
Advanced Biological and Medical Technologies: Biological Warfare Defense Unconventional Pathogen Countermeasures
The goal of the Unconventional Pathogen Countermeasures program is to develop and demonstrate defensive technologies that afford the greatest protection to uniformed warfighters, and the defense personnel who support them, during U.S. military operations. While no defense may stop a determined adversary from unleashing biological weapon, a sufficiently robust array of pathogen defenses and countermeasures , deterrents in their own right , will reduce the probable damage that would result from biological weapons used in a particular operation.
The most sinister offensive biological warfare scenario employs surprise, immediate proximity, and rapidly lethal, persistent agents in overwhelming quantities. Under these circumstances, real-time sensing, donning of physical protection, and conventional nonmedical countermeasures are only marginally effective. An effective operational defense ideally requires instantly available or emplaced countermeasures that can defeat biological threats as they enter the body and before they reach and attack target cells and tissues.
The focus of the Unconventional Pathogen Countermeasures program is the development of revolutionary, broad-spectrum, medical countermeasures against significantly pathogenic microorganisms and/or their pathogenic products. These countermeasures will be versatile enough to eliminate biological threats, whether from natural sources or modified through bioengineering or other manipulation. They will also have the potential to provide protection both within the body and at the most common portals of entry (e.g., inhalation, ingestion, transcutaneous). Strategies include but are not limited to:
Defeat of a pathogen's ability to enter the body, traverse the bloodstream or lymphatics, and enter target tissues.
Identification of novel pathogen vulnerabilities based on fundamental, critical molecular mechanisms of survival or pathogenesis (e.g., Type III secretion, cellular energetics, virulence modulation).
Construction of unique, robust vehicles for the delivery of countermeasures into or within the body.
Modulation of the advantageous and/or deleterious aspects of the immune response to significantly pathogenic microorganisms and/or their pathogenic products in the body.
CHEMTRAILS & THE BLACK DEATH
Excerpted from:
http://www.theforbiddenknowledge.com/chemtrails/index.htm
A great many people throughout Europe and other Plague stricken regions of the world were reporting that outbreaks of the Plague were caused by foul-smelling "mists". Those mists frequently appeared after unusually bright lights in the sky. The historian quickly discovers that "mists" were reported far more frequently and in many more locations than were rodent infestations. The Plague years were, in fact, a period of heavy UFO activity.
LUCAS : Flu comes from Outer Space, claim scientists
Excerpted from : http://members.aol.com/rubie2zday/index.html#flu
In a report to be published in the journal Current Science, they claim the outbreak was caused by DUST deposited high in the atmosphere by passing comets being forced down to earth by energy generated by cooler patches on the sun's surface, known as sunspots.
They reach the peak of their activity, the maxima, every 11 years... The latest cycle began to peak in September and the maxima is due sometime this year.
-- Bill Hamilton Executive Director Skywatch International, Inc.
Website: home.earthlink.net/~skywatcher22
And furthermore:
Maxygen Announces $6.7 Million Grant
from DARPA to Develop Aerosolized Vaccines
1-22-2000
Redwood City, CA, September 28, 1999. Maxygen announced today that it has received a $6.7 million three-year grant from the Defense Advanced Research Agency (DARPA) to use its proprietary MolecularBreeding directed evolution technology (also known as "DNA Shuffling") to develop aerosol-based vaccines to protect against a broad spectrum of pathogens.
Aerosol delivery of prophylactic and therapeutic agents is potentially the simplest and most cost-effective way to protect or treat humans and animals from disease epidemics. In addition to this recent DARPA grant, Maxygen is the recipient of two additional DARPA grants in the vaccine area. In February 1998, Maxygen received a $5.6 million grant to evolve novel DNA vectors for efficient delivery and expression of pathogen antigens, and in April 1999, the Company received a grant of $7.7 million to generate novel vaccine antigens for a wide range of pathogens.
Maxygen, Inc., headquartered in Redwood City, CA is a private biotechnology company that is focused on the development of novel and improved commercial products using its proprietary MolecularBreeding directed evolution technology for a variety of industries including human therapeutics, chemicals, vaccines, industrial enzymes, and agriculture. The Company is the leader in nucleic acid recombination technologies for imparting new properties into single genes, multi-gene systems, pathways, vectors and genomes.
Maxygen has commercial relationships with several companies including Novo Nordisk in certain areas of industrial enzymes, Pioneer Hi-Bred and ZenecaAgrochemicals for specific products in agriculture and DSM Anti-Infectives for improved manufacturing of certain classes of penicillin antibiotics. Maxygen was founded in a March 1997 spinout from Glaxo Wellcome-Affymax, led by biotech entrepreneur Alejandro Zaffaroni, and MolecularBreeding inventor Pim Stemmer.
-- Scooter (brucej@infoave.net), January 23, 2000
Liz, the fact IS that ethylene dibromide IS a fuel enhancer. Like it
or not, it is an excellent source for human depopulation, info.
courtesy of the EPA also known as the environmental protection agency.
You can find the following reference material here:
http://www.epa.gov/ttn/uatw/hlthef/ethyl-di.html
ETHYLENE DIBROMIDE
106-93-4
Hazard Summary
Ethylene dibromide is extremely toxic to humans; exposure to high
concentrations of ethylene dibromide through inhalation, ingestion,
or skin contact can result in death. Changes in the liver and kidney
have been noted in humans who died from ingestion of ethylene
dibromide.
The chronic (long-term) effects of exposure to ethylene dibromide
have not been well documented in humans. Animal studies indicate that
chronic exposure to ethylene dibromide may result in toxic effects to
the liver, kidney, and the testis, irrespective of the route of
exposure.
The U.S. Environmental Protection Agency (EPA) has not established a
Reference Dose (RfD) for ethylene dibromide.
The Reference Concentration (RfC) for ethylene dibromide is currently
under review by Environmental Protection Agency (EPA). However, EPA
has calculated a provisional RfC of 0.0002 mg/m3 for ethylene
dibromide.
Developmental effects have not been documented in humans exposed to
ethylene dibromide. Limited data on men occupationally exposed to
ethylene dibromide indicate that long-term exposure to ethylene
dibromide can impair reproduction by damaging sperm cells in the
testicles.
Animal studies have demonstrated reproductive and developmental
effects from ethylene dibromide exposure. Animals that breathed or
ate food containing ethylene dibromide for short or long periods were
less fertile than control animals or had abnormal sperm. Pregnant
animals that were sick from exposure to ethylene dibromide have had
pups with birth defects.
Human data are considered inadequate in providing evidence of cancer
by exposure to ethylene dibromide. Several animal studies indicate
that long-term exposure to ethylene dibromide increases the
incidences of a variety of tumors in rats and mice in both sexes by
all routes of exposure. EPA has classified ethylene dibromide as a
Group B2, a probable human carcinogen of medium carcinogenic hazard,
with a 1/ED10 value of 2.1 per (mg/kg)/db and an inhalation unit risk
estimate of 2.2 W 10-4 (5g/m3)-1.
The RfC is not a direct estimator of risk but rather a reference
point to gauge the potential effects. Exceedance of the RfC does not
imply that an adverse health effect would necessarily occur. As the
amount and frequency of exposures exceeding the RfC increase, the
probability of adverse health effects also increases. The provisional
RfC is a value that has had some form of Agency review, but it does
not appear on the Integrated Risk Information System (IRIS).
The 1/ED10 value is a measure of the carcinogenic potency of a
chemical. The value reported here has been proposed in the hazard
ranking of hazardous air pollutants in EPA's proposed rulemaking
(Section 112(g) of the Clean Air Act, April 1994).
Please Note: The main sources of information for this fact sheet are
EPA's IRIS, which contains information on the carcinogenic effects of
ethylene dibromide including the unit cancer risk for inhalation
exposure, and the Agency for Toxic Substances and Disease Registry's
(ATSDR's) Toxicological Profile for 1,2-Dibromoethane. Other
secondary sources include the Hazardous Substances Data Bank (HSDB),
a database of summaries of peer-reviewed literature, and the Registry
of Toxic Effects of Chemical Substances (RTECS), a database of toxic
effects that are not peer reviewed.
Environmental/Occupational Exposure
Possible sources of ethylene dibromide emissions to the ambient air
are production and processing facilities. (1)
Exposure could occur from inhalation of ambient air near industries
that use ethylene dibromide. (1)
The most important route of exposure to ethylene dibromide for most
members of the general population is through the ingestion of
contaminated drinking water (especially well water). Another place
for exposure is near a chemical waste site where ethylene dibromide
has leaked into water or soil. (1)
Assessing Personal Exposure- There is no known reliable medical test
to determine whether someone has been exposed to ethylene dibromide.
(1)
Health Hazard Information- Acute Effects:
Clinical signs in humans and animals related to acute inhalation
exposure to ethylene dibromide are depression and collapse. Ethylene
dibromide is a severe skin irritant that can cause blistering. (1,2)
Exposure to high concentrations of ethylene dibromide through
inhalation, ingestion, or skin contact can result in death. Changes
in the liver and kidney are reported in humans who died from
ingestion of ethylene dibromide. (1,2)
Tests involving acute exposure of animals, such as the LD50 test in
rats, have shown ethylene dibromide to have high acute toxicity from
oral exposure, while the LC50 test in rats has demonstrated moderate
acute toxicity from inhalation exposure. (3)
Chronic Effects (Noncancer): The chronic effects of exposure to
ethylene dibromide have not been documented in humans. In one case in
which a worker breathed ethylene dibromide for several years, he
developed bronchitis, headache, and depression. His health improved
after he stopped breathing air contaminated with ethylene dibromide.
(1,2)
Animal studies indicate that prolonged exposure to ethylene dibromide
may result in toxic effects to the liver, kidney, and the testis
whether by inhalation, ingestion, or skin contact. (1,2)
EPA has not established an RfD for ethylene dibromide. (4)
The RfC is currently under review by EPA. (4)
EPA has calculated a provisional RfC of 0.0002 mg/m3 for ethylene
dibromide. (5)
Reproductive Effects/Developmental: Developmental effects have not
been documented in humans. Limited data on men occupationally exposed
to ethylene dibromide indicate that long-term exposure to ethylene
dibromide can impair reproduction by damaging sperm cells in the
testicles. (1,2)
Animals that breathed or ate food containing ethylene dibromide for
short or long periods were less fertile than control animals or had
abnormal sperm. Pregnant animals that were sick from exposure to
ethylene dibromide have had pups with birth defects. (1,2)
Cancer Risk: Two cancer studies on workers exposed to ethylene
dibromide have been carried out. Neither study reported a
statistically significant increase in cancer mortality; however these
studies are considered inadequate due to confounding factors. (4)
Several animal studies indicate that long-term exposure to ethylene
dibromide increases the incidences of a variety of tumors in rats and
mice in both sexes by inhalation, by gavage (the placing of ethylene
dibromide experimentally in the stomach), or by administration to the
skin. (4)
EPA considers ethylene dibromide to be a probable human carcinogen
(cancer-causing agent) and has ranked it in EPA's Group B2. (4)
EPA uses mathematical models, based on animal studies, to estimate
the probability of a person developing cancer from breathing air
containing a specified concentration of a chemical. EPA has
calculated an inhalation unit risk estimate of 2.2 W 10-4 (5g/m3)-1.
EPA estimates that, if an individual were to breathe air containing
ethylene dibromide at 0.005 g/m3(1) over his or her entire lifetime,
that person would theoretically have no more than a one-in-a-million
increased chance of developing cancer as a direct result of breathing
air containing this chemical. Similarly, EPA estimates that breathing
air containing 0.05 5g/m3 would result in not greater than a one-in-
hundred thousand increased chance of developing cancer, and air
containing 0.5 5g/m3 would result in not greater than a one-in-ten
thousand increased chance of developing cancer. (7)
EPA's Office of Air Quality Planning and Standards, for a hazard
ranking under Section 112(g) of the Clean Air Act Amendments, has
ranked ethylene dibromide in the nonthreshold category. The 1/ED10
value is 2.1 per (mg/kg)/d and this would place it in the medium
category under Superfund's ranking for carcinogenic hazard. (6)
Physical Properties~ Ethylene dibromide is a colorless liquid with a
mild sweet odor, like chloroform. (1,7)
Ethylene dibromide is slightly soluble in water. (1,7)
The chemical formula for ethylene dibromide is C2H4Br2, and it has a
molecular weight of 187.88 g/mol. (1,7)
The vapor pressure for ethylene dibromide is 11.0 mm Hg at 25 C, and
it has a log octanol/water partition coefficient (Log Kow) of 86.
(1).
Uses~ Ethylene dibromide has been used mainly as an additive to
leaded gasoline. This use is currently declining due to the increased
regulation of leaded gasoline. (1)
Ethylene dibromide was used as a fumigant to protect against insects,
pests, and nematodes in citrus, vegetable, and grain crops, and as a
fumigant for turf, particularly on golf courses. In 1984, EPA banned
its use as a soil and grain fumigant. (1)
Ethylene dibromide is currently used in the treatment of felled logs
for bark beetles, termite control, control of wax moths in beehives,
spot treatment of milling machinery and for Japanese beetle control
on ornamental plants. (1)
Ethylene dibromide is also used as an intermediate for dyes, resins,
waxes, and gums. (1)
-- OR (orwelliator@biosys.net), January 24, 2000.